Estimated Medicare Part D Savings From Generic Drugs With a Skinny Label

被引：4

作者：

Egilman, Alexander C.

Kesselheim, Aaron S.

Sarpatwari, Ameet

Rome, Benjamin N.

机构：

[1] Brigham & Womens Hosp, Dept Med, Program Regulat Therapeut & Law PORTAL, Div Pharmacoepidemiol & Pharmacoecon, Boston, MA USA

[2] Harvard Med Sch, Boston, MA USA

来源：

ANNALS OF INTERNAL MEDICINE | 2024年 / 177卷 / 06期

关键词：

D O I：

10.7326/M23-3212

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：833 / 835

页数：3

共 5 条

[1] Frequency of Approval and Marketing of Biosimilars With a Skinny Label and Associated Medicare Savings [J].

Egilman, Alexander C. C. ;

Van de Wiele, Victor L. L. ;

Rome, Benjamin N. N. ;

Darrow, Jonathan J. J. ;

Tu, S. Sean ;

Kesselheim, Aaron S. S. ;

Sarpatwari, Ameet .

JAMA INTERNAL MEDICINE, 2023, 183 (01) :82-84

[2]

Ippolito Benedic, 2022, Health Affairs Forefront (blog), DOI [DOI 10.1377/FOREFRONT.20220308.712815, 10.1377/forefront.20220308.712815/]

[3] Indication-Specific Generic Uptake of Imatinib Demonstrates the Impact of Skinny Labeling [J].

Walsh, Bryan S. ;

Kesselheim, Aaron S. ;

Sarpatwari, Ameet ;

Rome, Benjamin N. .

JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (10) :1102-+

[4] A Court Decision on "Skinny Labeling" Another Challenge for Less Expensive Drugs [J].

Walsh, Bryan S. ;

Bloomfield, Doni ;

Kesselheim, Aaron S. .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2021, 326 (14) :1371-1372

[5] Frequency of First Generic Drug Approvals With "Skinny Labels" in the United States [J].

Walsh, Bryan S. ;

Sarpatwari, Ameet ;

Rome, Benjamin N. ;

Kesselheim, Aaron S. .

JAMA INTERNAL MEDICINE, 2021, 181 (07) :995-+

← 1 →